Literature DB >> 22954422

Pressure overload induces early morphological changes in the heart.

Colby A Souders1, Thomas K Borg, Indroneal Banerjee, Troy A Baudino.   

Abstract

Cardiac hypertrophy, whether pathological or physiological, induces a variety of additional morphological and physiological changes in the heart, including altered contractility and hemodynamics. Events exacerbating these changes are documented during later stages of hypertrophy (usually termed pathological hypertrophy). Few studies document the morphological and physiological changes during early physiological hypertrophy. We define acute cardiac remodeling events in response to transverse aortic constriction (TAC), including temporal changes in hypertrophy, collagen deposition, capillary density, and the cell populations responsible for these changes. Cardiac hypertrophy induced by TAC in mice was detected 2 days after surgery (as measured by heart weight, myocyte width, and wall thickness) and peaked by day 7. Picrosirius staining revealed increased collagen deposition 7 days after TAC; immunostaining and flow cytometry indicated a concurrent increase in fibroblasts. The findings correlated with angiogenesis in TAC hearts; a decrease in capillary density was observed at day 2, with recovery to sham-surgery levels by day 7. Increased pericyte levels, which were observed 2 days after TAC, may mediate this angiogenic transition. Gene expression suggests a coordinated response in growth, extracellular matrix, and angiogenic factors to mediate the observed morphological changes. Our data demonstrate that morphological changes in response to cardiovascular injury occur rapidly, and the present findings allow correlation of specific events that facilitate these changes.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954422      PMCID: PMC3463627          DOI: 10.1016/j.ajpath.2012.06.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Temporal alterations in cardiac fibroblast function following induction of pressure overload.

Authors:  James A Stewart; Erin P Massey; Charity Fix; Jinyu Zhu; Edie C Goldsmith; Wayne Carver
Journal:  Cell Tissue Res       Date:  2010-03-09       Impact factor: 5.249

Review 3.  The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities.

Authors:  Rudolf A De Boer; Yigal M Pinto; Dirk J Van Veldhuisen
Journal:  Microcirculation       Date:  2003-04       Impact factor: 2.628

4.  Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats.

Authors:  D Susic; J Varagic; E D Frohlich
Journal:  J Hypertens       Date:  1999-08       Impact factor: 4.844

5.  Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice.

Authors:  Giuseppe Marano; Sergio Palazzesi; Alessandro Vergari; Liviana Catalano; Simona Gaudi; Claudia Testa; Rossella Canese; Giulia Carpinelli; Franca Podo; Alberto U Ferrari
Journal:  Pflugers Arch       Date:  2003-04-25       Impact factor: 3.657

6.  IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.

Authors:  Indroneal Banerjee; John W Fuseler; Arti R Intwala; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

Review 7.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

Authors:  K T Weber; Y Sun; S C Tyagi; J P Cleutjens
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

Review 8.  Ventricular remodeling.

Authors:  B Maisch
Journal:  Cardiology       Date:  1996       Impact factor: 1.869

Review 9.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

10.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

Authors:  L E Benjamin; I Hemo; E Keshet
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  33 in total

Review 1.  Cardiac myocyte-fibroblast interactions and the coronary vasculature.

Authors:  Stephanie L K Bowers; Troy A Baudino
Journal:  J Cardiovasc Transl Res       Date:  2012-09-18       Impact factor: 4.132

2.  Cardiac fibroblasts in pressure overload hypertrophy: the enemy within?

Authors:  Nenad Bursac
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

3.  Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.

Authors:  Yanzhen Li; Daniel Song; Lan Mao; Dennis M Abraham; Nenad Bursac
Journal:  Biomaterials       Date:  2020-01-29       Impact factor: 12.479

Review 4.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

Review 5.  Pregnancy as a cardiac stress model.

Authors:  Eunhee Chung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

6.  Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.

Authors:  Laura Benschop; Sarah Schalekamp-Timmermans; Zoe A Broere-Brown; Jeanine E Roeters van Lennep; Vincent W V Jaddoe; Jolien W Roos-Hesselink; M Kamran Ikram; Eric A P Steegers; James M Roberts; Robin E Gandley
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

7.  Assessment of right ventricular structure and function in mouse model of pulmonary artery constriction by transthoracic echocardiography.

Authors:  Hui-Wen Cheng; Sudeshna Fisch; Susan Cheng; Michael Bauer; Soeun Ngoy; Yiling Qiu; Jian Guan; Shikha Mishra; Christopher Mbah; Ronglih Liao
Journal:  J Vis Exp       Date:  2014-02-03       Impact factor: 1.355

8.  A minimally invasive endovascular rabbit model for experimental induction of progressive myocardial hypertrophy.

Authors:  Grigorios Tsigkas; Konstantinos Katsanos; Efstratios Apostolakis; Evangelia Papadimitriou; Marina Koutsioumpa; George C Kagadis; Dimitra Koumoundourou; George Hahalis; Dimitrios Alexopoulos
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

9.  Resident fibroblast expansion during cardiac growth and remodeling.

Authors:  Malina J Ivey; Jill T Kuwabara; Jonathan T Pai; Richard E Moore; Zuyue Sun; Michelle D Tallquist
Journal:  J Mol Cell Cardiol       Date:  2017-11-20       Impact factor: 5.000

10.  Revisiting Cardiac Cellular Composition.

Authors:  Alexander R Pinto; Alexei Ilinykh; Malina J Ivey; Jill T Kuwabara; Michelle L D'Antoni; Ryan Debuque; Anjana Chandran; Lina Wang; Komal Arora; Nadia A Rosenthal; Michelle D Tallquist
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.